Single Cell Sequencing Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511241332

Publication Date:

November 28, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Single-cell sequencing refers to the amplification and sequencing of transcriptomes or genomes at the level of individual cells to detect single cells in the genome (Structural Variations-SVs; Copy number variants-CNVs; Single Nucleotide Variants-Single nucleotide variants-SNVs, etc.), transcriptomics (RNA expression level; alternative splicing of transcripts), epiomics (DNA methylation, etc.), proteomics and multiple omics data...
The global market for Single Cell Sequencing Platform was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Single Cell Sequencing Platform was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single Cell Sequencing Platform was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Single Cell Sequencing Platform was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Single Cell Sequencing Platform include 10x Genomics, BD, Fluidigm Corporation, Illumina/Bio-Rad, Takara Bio, 1CellBio and MissionBio, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Single Cell Sequencing Platform, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Single Cell Sequencing Platform by region & country, by Type, and by Application.
The Single Cell Sequencing Platform market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell Sequencing Platform.
Market Segmentation
By Company
10x Genomics
BD
Fluidigm Corporation
Illumina/Bio-Rad
Takara Bio
1CellBio
MissionBio
Segment by Type:
Microfluidic Separation
Microdroplet Separation
Microporous Separation
Combined Labeling
Other
Segment by Application
Neurobiology
Immunology
Cancer Medicine
Plant Biology
Forensics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Single Cell Sequencing Platform manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Single Cell Sequencing Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Single Cell Sequencing Platform in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Single Cell Sequencing Platform Product Introduction
1.2 Global Single Cell Sequencing Platform Market Size Forecast
1.3 Single Cell Sequencing Platform Market Trends & Drivers
1.3.1 Single Cell Sequencing Platform Industry Trends
1.3.2 Single Cell Sequencing Platform Market Drivers & Opportunity
1.3.3 Single Cell Sequencing Platform Market Challenges
1.3.4 Single Cell Sequencing Platform Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Single Cell Sequencing Platform Players Revenue Ranking (2023)
2.2 Global Single Cell Sequencing Platform Revenue by Company (2019-2024)
2.3 Key Companies Single Cell Sequencing Platform Manufacturing Base Distribution and Headquarters
2.4 Key Companies Single Cell Sequencing Platform Product Offered
2.5 Key Companies Time to Begin Mass Production of Single Cell Sequencing Platform
2.6 Single Cell Sequencing Platform Market Competitive Analysis
2.6.1 Single Cell Sequencing Platform Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Single Cell Sequencing Platform Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell Sequencing Platform as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Microfluidic Separation
3.1.2 Microdroplet Separation
3.1.3 Microporous Separation
3.1.4 Combined Labeling
3.1.5 Other
3.2 Global Single Cell Sequencing Platform Sales Value by Type
3.2.1 Global Single Cell Sequencing Platform Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Single Cell Sequencing Platform Sales Value, by Type (2019-2030)
3.2.3 Global Single Cell Sequencing Platform Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Neurobiology
4.1.2 Immunology
4.1.3 Cancer Medicine
4.1.4 Plant Biology
4.1.5 Forensics
4.1.6 Other
4.2 Global Single Cell Sequencing Platform Sales Value by Application
4.2.1 Global Single Cell Sequencing Platform Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Single Cell Sequencing Platform Sales Value, by Application (2019-2030)
4.2.3 Global Single Cell Sequencing Platform Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Single Cell Sequencing Platform Sales Value by Region
5.1.1 Global Single Cell Sequencing Platform Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Single Cell Sequencing Platform Sales Value by Region (2019-2024)
5.1.3 Global Single Cell Sequencing Platform Sales Value by Region (2025-2030)
5.1.4 Global Single Cell Sequencing Platform Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Single Cell Sequencing Platform Sales Value, 2019-2030
5.2.2 North America Single Cell Sequencing Platform Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Single Cell Sequencing Platform Sales Value, 2019-2030
5.3.2 Europe Single Cell Sequencing Platform Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Single Cell Sequencing Platform Sales Value, 2019-2030
5.4.2 Asia Pacific Single Cell Sequencing Platform Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Single Cell Sequencing Platform Sales Value, 2019-2030
5.5.2 South America Single Cell Sequencing Platform Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Single Cell Sequencing Platform Sales Value, 2019-2030
5.6.2 Middle East & Africa Single Cell Sequencing Platform Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Single Cell Sequencing Platform Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Single Cell Sequencing Platform Sales Value
6.3 United States
6.3.1 United States Single Cell Sequencing Platform Sales Value, 2019-2030
6.3.2 United States Single Cell Sequencing Platform Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Single Cell Sequencing Platform Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Single Cell Sequencing Platform Sales Value, 2019-2030
6.4.2 Europe Single Cell Sequencing Platform Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Single Cell Sequencing Platform Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Single Cell Sequencing Platform Sales Value, 2019-2030
6.5.2 China Single Cell Sequencing Platform Sales Value by Type (%), 2023 VS 2030
6.5.3 China Single Cell Sequencing Platform Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Single Cell Sequencing Platform Sales Value, 2019-2030
6.6.2 Japan Single Cell Sequencing Platform Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Single Cell Sequencing Platform Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Single Cell Sequencing Platform Sales Value, 2019-2030
6.7.2 South Korea Single Cell Sequencing Platform Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Single Cell Sequencing Platform Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Single Cell Sequencing Platform Sales Value, 2019-2030
6.8.2 Southeast Asia Single Cell Sequencing Platform Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Single Cell Sequencing Platform Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Single Cell Sequencing Platform Sales Value, 2019-2030
6.9.2 India Single Cell Sequencing Platform Sales Value by Type (%), 2023 VS 2030
6.9.3 India Single Cell Sequencing Platform Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 10x Genomics
7.1.1 10x Genomics Profile
7.1.2 10x Genomics Main Business
7.1.3 10x Genomics Single Cell Sequencing Platform Products, Services and Solutions
7.1.4 10x Genomics Single Cell Sequencing Platform Revenue (US$ Million) & (2019-2024)
7.1.5 10x Genomics Recent Developments
7.2 BD
7.2.1 BD Profile
7.2.2 BD Main Business
7.2.3 BD Single Cell Sequencing Platform Products, Services and Solutions
7.2.4 BD Single Cell Sequencing Platform Revenue (US$ Million) & (2019-2024)
7.2.5 BD Recent Developments
7.3 Fluidigm Corporation
7.3.1 Fluidigm Corporation Profile
7.3.2 Fluidigm Corporation Main Business
7.3.3 Fluidigm Corporation Single Cell Sequencing Platform Products, Services and Solutions
7.3.4 Fluidigm Corporation Single Cell Sequencing Platform Revenue (US$ Million) & (2019-2024)
7.3.5 Illumina/Bio-Rad Recent Developments
7.4 Illumina/Bio-Rad
7.4.1 Illumina/Bio-Rad Profile
7.4.2 Illumina/Bio-Rad Main Business
7.4.3 Illumina/Bio-Rad Single Cell Sequencing Platform Products, Services and Solutions
7.4.4 Illumina/Bio-Rad Single Cell Sequencing Platform Revenue (US$ Million) & (2019-2024)
7.4.5 Illumina/Bio-Rad Recent Developments
7.5 Takara Bio
7.5.1 Takara Bio Profile
7.5.2 Takara Bio Main Business
7.5.3 Takara Bio Single Cell Sequencing Platform Products, Services and Solutions
7.5.4 Takara Bio Single Cell Sequencing Platform Revenue (US$ Million) & (2019-2024)
7.5.5 Takara Bio Recent Developments
7.6 1CellBio
7.6.1 1CellBio Profile
7.6.2 1CellBio Main Business
7.6.3 1CellBio Single Cell Sequencing Platform Products, Services and Solutions
7.6.4 1CellBio Single Cell Sequencing Platform Revenue (US$ Million) & (2019-2024)
7.6.5 1CellBio Recent Developments
7.7 MissionBio
7.7.1 MissionBio Profile
7.7.2 MissionBio Main Business
7.7.3 MissionBio Single Cell Sequencing Platform Products, Services and Solutions
7.7.4 MissionBio Single Cell Sequencing Platform Revenue (US$ Million) & (2019-2024)
7.7.5 MissionBio Recent Developments
8 Industry Chain Analysis
8.1 Single Cell Sequencing Platform Industrial Chain
8.2 Single Cell Sequencing Platform Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Single Cell Sequencing Platform Sales Model
8.5.2 Sales Channel
8.5.3 Single Cell Sequencing Platform Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

10x Genomics
BD
Fluidigm Corporation
Illumina/Bio-Rad
Takara Bio
1CellBio
MissionBio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂